Keywords: valeant, retigabine, enters, ph, ii, phn, trial

Valeant's retigabine enters Ph II PHN trial

Article | 10 December 2007

Print This

The USA's Valeant Pharmaceuticals has enrolled the first patient in a Phase II clinical trial of retigabine for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in